Clinical Trial Update: Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial is recruiting to evaluate psilocybin in whole mushroom form for obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Psilocybin Whole Mushroom (psilocybin)

Snippet

Sponsor: Francisco A Moreno | Conditions: Obsessive-Compulsive Disorder | Phase 1 | Status: RECRUITING